PDCD1 and neoplasm: Advances in immune checkpoint inhibitors as well as non-responders to therapy highlight the importance of imaging programmed cell death-ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) within the microenvironment of any given tumor to truly understand the role of hypoxia.